Exploring the Use of Oral Pre-exposure Prophylaxis (PrEP) Among Women from Durban, South Africa as Part of the HIV Prevention Package in a Clinical Trial

HIV endpoint-driven clinical trials in Africa enroll women who are at heightened risk of acquiring HIV. In 2017, the South African Medical Research Council recommended the provision of oral pre-exposure prophylaxis (PrEP) in HIV prevention trials, at which time the Evidence for Contraceptive Options...

Descripción completa

Detalles Bibliográficos
Autores principales: Beesham, Ivana, Heffron, Renee, Evans, Shannon, Baeten, Jared M., Smit, Jenni, Beksinska, Mags, Mansoor, Leila E.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2020
Materias:
Original Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7973915/
https://www.ncbi.nlm.nih.gov/pubmed/33106996
http://dx.doi.org/10.1007/s10461-020-03072-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7973915/
https://www.ncbi.nlm.nih.gov/pubmed/33106996
http://dx.doi.org/10.1007/s10461-020-03072-0

Ejemplares similares